BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy.

Hengchang LiuRan WeiChunxiang LiZhixun ZhaoXu GuanMing YangZheng LiuXishan WangZheng Jiang

Published in: Cancer management and research (2020)

In conclusion, this study demonstrated that BMI was an independent prognostic factor for OS and CSS in LARC patients treated with nCRT followed TME. A nomogram incorporating BMI, neural invasion, pre-CA19-9, ypStage, age, and adjuvant chemotherapy could be helpful to predict the OS and CSS.

Keyphrases

prognostic factors
rectal cancer
locally advanced
body mass index
weight gain
squamous cell carcinoma
radiation therapy
lymph node metastasis
cell migration